Cancer Research Institute to bring together cancer patients, leading immunotherapy manufacturers, and Highland Falls community members for Second Annual Answer to Cancer Cycling and 5K Run/Walk Event Sponsored by Bristol-Myers Squibb on Saturday, June 10, 2017
30 days of educational and awareness programming and special events for patients, caregivers, and the public about cancer immunotherapy, clinical trials, and the need to fund more research
Data from four CRI-funded early-phase immunotherapy combination trials will be presented at the American Society for Clinical Oncology (ASCO) Annual meeting in Chicago in June.
Nonprofit Cancer Research Institute appoints pharmaceutical executive to lead its clinical research program
An innovative collaboration model designed to accelerate next-generation precision cancer immunotherapy through network of leading research centers and top scientists
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
July is Sarcoma Awareness Month. As a rare and difficult-to-treat form of cancer, effective drug treatments are urgently needed and immunotherapy for sarcoma shows promise.
Dr. Joan Levy, director of research at the Chordoma Foundation, discusses the current state of chordoma research and the recently launched partnership with CRI.